What are the Historical Developments and Current Growth Metrics of the Hydronephrosis Market?
The hydronephrosis market has seen considerable growth due to a variety of factors.
• The market for hydronephrosis has witnessed accelerated expansion in the past few years. This rapid growth is projected to continue, with the market size set to increase from $3.06 billion in 2024 to $3.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.5%.
The impressive growth during the historic period can be credited to escalating cases of kidney stones, frequency of urinary tract infections, an aging population, heightened awareness leading to early diagnosis, and a surge in healthcare spending.
What is the Forecasted Market Size and CAGR for the Hydronephrosis Market?
The hydronephrosis market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for hydronephrosis is anticipated to experience a robust increase in the upcoming years, expanding to $4.99 billion in 2029 with a 10.2% compound annual growth rate (CAGR).
The predicted growth during this period can be ascribed to the escalating incidence of chronic kidney diseases, the rising tendency towards minimally invasive surgical procedures, heightened awareness towards early detection, enhancements in healthcare infrastructures, and the emergence of fresh treatment alternatives. Key trends during the forecast period consist of developments in personalized medicine, growth in the application of artificial intelligence in diagnostics, progress in non-invasive treatment techniques, an uptick in patient-centric healthcare strategies, and the incorporation of telemedicine in the field of nephrology.
What Key Factors and Trends Are Driving The Growth Hydronephrosis Market?
The surge in kidney disease cases is anticipated to boost the expansion of the hydronephrosis market. Kidney disease, alternatively termed renal disease or nephropathy, encompasses various conditions denoting damage to the kidneys, hindering their capacity to effectively filter blood. The surge in cases of kidney diseases is a result of multiple factors, including a rising incidence of diabetes and hypertension, obesity, an aging population, as well as genetic and ethnic elements. Hydronephrosis treatment targets the root cause of the urinary obstruction, deploying medications, surgeries, or other tools to reinstate normal urine flow. For example, Kidney Research UK, a non-profit organization based in the UK, reveals in a June 2023 report that around 7.2 million people in the UK, over 10% of the populace, presently live with chronic kidney disease. Among these, 3.25 million are grappling with advanced stages of the disease, while an additional 3.9 million are in the initial stages. By 2033, the count of individuals suffering from chronic kidney disease is expected to escalate to 7.61 million. Thus, the escalating prevalence of kidney diseases is propelling the hydronephrosis market's growth.
What Are The Market Segments In The Hydronephrosis Market?
The hydronephrosis market covered in this report is segmented –
1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis
2) By Indication: Intrinsic, Extrinsic
3) By Diagnosis: Laboratory Test, Imaging
4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments
Subsegments:
1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis
2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis
Pre-Book The Hydronephrosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Hydronephrosis Market?
Key players in the hydronephrosis market, such as drainage catheters manufacturers, are focusing on the creation of innovative products to improve patient care, providing efficient and minimally invasive options for urine removal from the kidneys. Drainage catheters are pivotal medical tools used for eliminating body fluids such as urine or blood, thus mitigating pressure or averting liquid buildup. For instance, Argon Medical Devices Inc., a renowned manufacturer based in the US, specializing in medical products, launched the SKATER Mini-Loop drainage catheter in October 2024. This catheter, designed for the non-invasive drainage of excess fluids in the body, is inserted into the skin under image guidance. It features a 40% smaller loop, ensuring successful placement and efficient drainage even from smaller spaces. Recognized for its longevity, non-kinking feature, and compatibility with alcohol, this catheter enhances its practicality in interventional procedures. The unveiling of the SKATER Mini-Loop bolsters Argon's drainage line, aiming to improve patient results and simplify the draining process for healthcare staff.
Who Are the Key Players In The Hydronephrosis Market?
Major companies operating in the hydronephrosis market are:
• AbbVie Inc.
• Boston Scientific Corporation
• Novartis AG
• 3M Company
• F. Hoffmann-La Roche Ltd
• Medtronic PLC
• Amgen Inc.
• Stryker Corporation
• Thermo Fisher Scientific Inc.
• B. Braun Group
• Terumo Interventional Systems
• Sigma-Aldrich Co
• Coloplast A/S
• Cook Medical
• KARL STORZ SE & Co. KG
• Spire Healthcare Group plc
• Promega Corporation
• NantHealth Inc.
• UroGen Pharma Ltd.
• Natus Medical Incorporated
• Renal Associates P.A.
• Urologix Inc.
• Savant Medical Group
What Are The Regional Insights Into The Hydronephrosis Market?
North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
